Skip to main content
. 2023 Apr 17;15(4):e37680. doi: 10.7759/cureus.37680

Table 7. Comparison of side effects of trials NCT01586260, NCT02395666* with those of NCT02559778**.

*[41], **[57]

ALT: alanine transaminase; AST: aspartate transaminase; INR: international normalized ratio

Side effect (NCT01586260, NCT02395666) (n=140) [41] (NCT02559778) (n=20) [57]
Anemia 6 10
Neutrophil count decrease 11 10
Platelet count decrease 2 14
Febrile neutropenia - 11
White blood cell decrease 3 7
Abdominal pain 1 -
Agitation 1 -
Alopecia 2 -
ALT elevation 12 1
AST elevation 9 1
Alkaline phosphatase elevation 1 -
Anorexia 1 1
Cellulitis - 1
Dehydration - 1
Diarrhea 7 1
Epistaxis - 2
Fever 4 -
Hearing loss 6 -
Hypoglycemia 1 -
Hypokalemia 2 6
Hyponatremia - 3
Hypophosphatemia - 5
Infection (other) 3 4
Infection, middle ear 6 -
INR elevated 1 -
Insomnia 1 -
Nausea - 4
Pain 2 -
Post-nasal drip 1 -
Rash 3 -
Sepsis - 3
Skin infection - 1
Thromboembolic event - 1
Vomiting 1 3
Weight gain 1 -
Weight loss - 1